ANIP icon

ANI Pharmaceuticals
ANIP

Overview Fund Activity

227 hedge funds and large institutions have $1.28B invested in ANI Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 89 increasing their positions, 73 reducing their positions, and 23 closing their positions.

Holders
227
Holders Change
–
Holders Change %
0%
% of All Funds
3.05%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
28
Increased
89
Reduced
73
Closed
23
Calls
$72K
Puts
$535K
Net Calls
-$463K
Net Calls Change
-$135K

Top Buyers

1
NL
1
Nuveen LLC
North Carolina
$24.2M
2
RCMNY
2
Rubric Capital Management (New York)
New York
$16.8M
3
FGP
3
Freestone Grove Partners
California
$12.7M
4
Millennium Management
4
Millennium Management
New York
$65.5M
5
Teacher Retirement System of Texas
5
Teacher Retirement System of Texas
Texas
$9.62M

Top Sellers

1
Goldman Sachs
1
Goldman Sachs
New York
$13.4M
2
Morgan Stanley
2
Morgan Stanley
New York
$13.1M
3
SCM
3
Soleus Capital Management
Connecticut
$3.31M
4
Nomura Holdings
4
Nomura Holdings
Japan
$2.85M
5
WP
5
Woodline Partners
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
C
251
Covestor
United Kingdom
$0 2 – –
7 8 9 10
11